Mounjaro’s FDA prescribing information does not include a tapering or weaning protocol, which means there’s no officially approved step-down schedule. In practice, most providers who help patients discontinue tirzepatide (Mounjaro’s active ingredient) use a gradual dose-reduction approach to minimize weight regain and digestive rebound, though the specifics vary by clinic. The drug has a half-life of about five days, meaning it takes roughly 30 days after your last injection to fully clear your system.
Why There’s No Official Tapering Schedule
Unlike medications such as antidepressants or corticosteroids, Mounjaro doesn’t cause physical withdrawal symptoms when stopped. You won’t experience tremors, seizures, or the kind of dangerous rebound effects that make tapering medically necessary for some drugs. The FDA labeling only mentions abrupt discontinuation in two scenarios: suspected pancreatitis and serious allergic reactions, both of which call for stopping immediately.
That said, “no withdrawal symptoms” doesn’t mean stopping is consequence-free. The concern isn’t withdrawal in the traditional sense. It’s what happens to your weight, appetite, and metabolic health in the months that follow.
What Happens When You Stop
The clearest picture comes from the SURMOUNT-4 trial, which tracked people with obesity who lost about 20% of their body weight on tirzepatide over 36 weeks. Those who then switched to a placebo (effectively stopping the drug) regained an average of 14% of their body weight over the following year. Most participants regained 25% or more of the weight they had lost within that 52-week window.
The weight regain isn’t simply about willpower. Mounjaro works by suppressing appetite signals, slowing stomach emptying, and improving how your body handles insulin and blood sugar. When the drug leaves your system, those effects reverse. Hunger returns to pre-treatment levels, and your body’s metabolic set point pushes weight back toward where it started. The cardiometabolic improvements you gained, such as better blood pressure, cholesterol, and blood sugar control, also erode as weight comes back.
For people with Type 2 diabetes, the blood sugar rebound can be significant. A case series study found that six months after stopping tirzepatide, A1c levels had risen by 1.2 to 2.4 percentage points depending on the dose patients had been taking, with the 15 mg group seeing the largest increase. If you have diabetes, your provider will likely want a plan for alternative blood sugar management before you stop.
A Common Approach to Tapering
Although no standardized protocol exists, many clinicians use a reverse of the dose-escalation schedule you followed when starting Mounjaro. If you’re currently on 15 mg, a typical approach looks something like this:
- Step down to 10 mg for four to six weeks
- Step down to 7.5 mg for four to six weeks
- Step down to 5 mg for four to six weeks
- Step down to 2.5 mg for four to six weeks, then stop
The logic is straightforward: each step gives your body time to adjust to a slightly lower level of appetite suppression and metabolic support. Some providers move faster (every two to four weeks), while others extend each step if a patient notices a sharp return of hunger or rapid weight gain at a particular dose. This is a conversation to have with whoever prescribed your Mounjaro, because the right pace depends on your starting dose, how long you’ve been on the medication, and whether you’re also managing diabetes.
Because tirzepatide takes about 30 days to fully leave your body after the last dose, each step-down continues to provide some drug effect even as levels decline. This built-in buffer makes the transition at each step somewhat gentler than it might be with a shorter-acting medication.
Protecting Your Weight Loss After Stopping
The period during and after tapering is when your habits matter most. Mounjaro gave you a window of reduced appetite to build new eating patterns. The question is whether those patterns can hold once the pharmacological support is gone.
Protein intake is one of the most concrete levers you have. During weight loss, you lose both fat and lean muscle, and losing muscle slows your metabolism. Consuming 1.2 to 2.0 grams of protein per kilogram of body weight daily helps preserve that lean mass. For a 180-pound person, that’s roughly 98 to 164 grams of protein per day. If you struggled to eat enough on Mounjaro due to reduced appetite, your protein intake may have been inadequate during treatment, making this even more important as you taper down and your appetite returns.
Resistance training is the other major tool for protecting lean mass. Cardio helps with overall health, but lifting weights or doing bodyweight exercises sends the signal your body needs to hold onto muscle tissue rather than breaking it down.
There’s also early evidence that certain medications may help bridge the gap. A two-year observational study followed women who stopped semaglutide (a similar medication) but continued taking metformin alongside lifestyle changes. Two years later, they had regained only about one-third of the weight they initially lost, and 84% still weighed less than they did before starting treatment. This is a small study in a specific population (women with polycystic ovary syndrome), so it doesn’t translate directly to everyone stopping Mounjaro. But it suggests that combination strategies, rather than just stopping cold, may help maintain results. Ask your provider whether a maintenance medication makes sense for your situation.
Signs You’re Tapering Too Quickly
There’s no blood test that tells you the taper is going poorly. Instead, pay attention to practical signals. A sharp increase in hunger between meals, cravings that feel qualitatively different from normal appetite, rapid weight gain of more than two to three pounds per week (beyond normal water weight fluctuation), and for diabetics, fasting blood sugar readings climbing noticeably. Any of these suggest your body hasn’t adjusted to the current dose reduction, and staying at that level for a few more weeks before stepping down again is reasonable.
Digestive changes can also occur. Some people notice looser stools or changes in digestion as the stomach-slowing effect of tirzepatide fades. This is usually temporary and resolves within a few weeks at each new dose level.
When Staying on a Lower Dose Makes Sense
Not everyone needs to come off Mounjaro entirely. The SURMOUNT-4 data reinforced what obesity researchers have long argued: for many people, obesity is a chronic condition that benefits from ongoing treatment, similar to blood pressure medication. If your reason for stopping is cost, side effects, or a supply issue rather than a medical need to discontinue, your provider may suggest maintaining on the lowest effective dose (often 5 mg or even 2.5 mg) rather than stopping completely. A lower maintenance dose costs less, produces fewer side effects, and preserves more of the metabolic benefit than full discontinuation.
If you’re stopping because you’ve reached your goal weight and feel ready, the gradual taper with strong lifestyle habits gives you the best chance of holding onto your results. Just go in knowing that some weight regain is the norm, not the exception, and having a plan for it puts you ahead of the curve.